 Travis Nemkov
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 43 | 2024 | 590 | 6.220 |
Why?
| | Metabolomics | 31 | 2024 | 538 | 3.700 |
Why?
| | Metabolome | 23 | 2023 | 287 | 2.930 |
Why?
| | Blood Preservation | 23 | 2024 | 263 | 2.710 |
Why?
| | Blood Donors | 8 | 2024 | 89 | 2.170 |
Why?
| | Mass Spectrometry | 11 | 2019 | 646 | 1.440 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 124 | 1.410 |
Why?
| | Erythrocyte Transfusion | 11 | 2023 | 187 | 1.320 |
Why?
| | Glycolysis | 18 | 2023 | 224 | 1.110 |
Why?
| | Hypoxia | 10 | 2023 | 937 | 1.090 |
Why?
| | Amino Acids | 10 | 2023 | 456 | 1.050 |
Why?
| | Energy Metabolism | 10 | 2021 | 713 | 0.980 |
Why?
| | Oxidative Stress | 12 | 2022 | 1095 | 0.970 |
Why?
| | Hemolysis | 4 | 2024 | 146 | 0.960 |
Why?
| | Membrane Lipids | 2 | 2021 | 87 | 0.890 |
Why?
| | Proteomics | 7 | 2022 | 859 | 0.870 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 193 | 0.850 |
Why?
| | Athletic Performance | 1 | 2023 | 43 | 0.840 |
Why?
| | Erythroblasts | 1 | 2022 | 12 | 0.830 |
Why?
| | Drosophila Proteins | 5 | 2024 | 159 | 0.810 |
Why?
| | Lipid Metabolism | 6 | 2021 | 449 | 0.790 |
Why?
| | Purines | 4 | 2022 | 159 | 0.760 |
Why?
| | Animals | 59 | 2024 | 32174 | 0.720 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.710 |
Why?
| | Physical Exertion | 1 | 2021 | 208 | 0.680 |
Why?
| | Leukemia | 2 | 2019 | 209 | 0.680 |
Why?
| | Fatty Acids | 7 | 2024 | 386 | 0.670 |
Why?
| | Prescription Drugs | 1 | 2021 | 116 | 0.660 |
Why?
| | Carbon | 2 | 2017 | 160 | 0.650 |
Why?
| | Drosophila melanogaster | 6 | 2024 | 190 | 0.640 |
Why?
| | Lymph | 2 | 2016 | 40 | 0.630 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 538 | 0.630 |
Why?
| | Cell Death | 1 | 2020 | 326 | 0.630 |
Why?
| | Hypoxanthine | 1 | 2017 | 10 | 0.600 |
Why?
| | Muscle, Skeletal | 8 | 2022 | 1459 | 0.590 |
Why?
| | Mice | 31 | 2023 | 15093 | 0.590 |
Why?
| | Bone Marrow | 1 | 2018 | 249 | 0.570 |
Why?
| | Iron | 1 | 2018 | 235 | 0.570 |
Why?
| | Humans | 88 | 2024 | 115933 | 0.550 |
Why?
| | Exercise | 3 | 2023 | 1612 | 0.540 |
Why?
| | Altitude Sickness | 5 | 2018 | 152 | 0.540 |
Why?
| | Nitrogen | 1 | 2017 | 149 | 0.530 |
Why?
| | Transfusion Medicine | 1 | 2015 | 8 | 0.530 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 924 | 0.530 |
Why?
| | Kynurenine | 5 | 2024 | 80 | 0.510 |
Why?
| | Lipids | 1 | 2019 | 589 | 0.500 |
Why?
| | Hemoglobins | 4 | 2022 | 313 | 0.480 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 30 | 0.470 |
Why?
| | Aging | 7 | 2021 | 1635 | 0.460 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.450 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4782 | 0.420 |
Why?
| | Taste Buds | 1 | 2015 | 209 | 0.420 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 331 | 0.420 |
Why?
| | Hemorrhage | 2 | 2022 | 618 | 0.410 |
Why?
| | Inflammation | 6 | 2021 | 2502 | 0.400 |
Why?
| | Healthy Volunteers | 7 | 2021 | 192 | 0.400 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 477 | 0.390 |
Why?
| | Oxygen | 5 | 2020 | 837 | 0.390 |
Why?
| | Anemia | 2 | 2023 | 144 | 0.370 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 638 | 0.370 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 477 | 0.360 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 171 | 0.360 |
Why?
| | Male | 41 | 2023 | 56129 | 0.360 |
Why?
| | Altitude | 4 | 2023 | 409 | 0.350 |
Why?
| | Flavones | 2 | 2019 | 10 | 0.340 |
Why?
| | Sphingosine | 3 | 2023 | 32 | 0.340 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2262 | 0.340 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 119 | 0.340 |
Why?
| | Blood Banks | 3 | 2019 | 40 | 0.330 |
Why?
| | Lysophospholipids | 3 | 2023 | 65 | 0.330 |
Why?
| | Exercise Tolerance | 2 | 2023 | 223 | 0.330 |
Why?
| | Biomarkers | 8 | 2023 | 3478 | 0.320 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 13 | 0.310 |
Why?
| | Thrombosis | 2 | 2022 | 302 | 0.300 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 363 | 0.300 |
Why?
| | Hematopoietic Stem Cells | 2 | 2023 | 356 | 0.300 |
Why?
| | Acclimatization | 3 | 2018 | 132 | 0.300 |
Why?
| | Proteome | 4 | 2020 | 346 | 0.300 |
Why?
| | Hematopoiesis | 2 | 2018 | 175 | 0.280 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 43 | 0.280 |
Why?
| | Female | 39 | 2023 | 60095 | 0.280 |
Why?
| | Mammals | 3 | 2023 | 252 | 0.270 |
Why?
| | Wounds and Injuries | 3 | 2020 | 731 | 0.270 |
Why?
| | Adult | 23 | 2023 | 30830 | 0.270 |
Why?
| | Tryptophan | 4 | 2021 | 136 | 0.270 |
Why?
| | Sciuridae | 2 | 2019 | 142 | 0.270 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 49 | 0.270 |
Why?
| | Carnitine | 3 | 2021 | 61 | 0.270 |
Why?
| | Plasma | 3 | 2017 | 213 | 0.270 |
Why?
| | Isotope Labeling | 2 | 2017 | 76 | 0.270 |
Why?
| | Insulin Resistance | 3 | 2021 | 1078 | 0.270 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 447 | 0.270 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 141 | 0.260 |
Why?
| | Collagen | 2 | 2020 | 415 | 0.260 |
Why?
| | Drosophila | 2 | 2024 | 132 | 0.260 |
Why?
| | Rats | 7 | 2021 | 5035 | 0.260 |
Why?
| | Erythropoiesis | 2 | 2023 | 33 | 0.260 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 344 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 336 | 0.250 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 2752 | 0.250 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 46 | 0.250 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 465 | 0.250 |
Why?
| | Polyamines | 2 | 2022 | 39 | 0.240 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 157 | 0.240 |
Why?
| | Interleukin-1 | 2 | 2021 | 971 | 0.240 |
Why?
| | Blood Platelets | 2 | 2019 | 350 | 0.240 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 92 | 0.240 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.230 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 168 | 0.230 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 20 | 0.230 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 12 | 0.230 |
Why?
| | Blood Group Antigens | 1 | 2023 | 14 | 0.230 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 10 | 0.230 |
Why?
| | Oxygen Consumption | 3 | 2023 | 573 | 0.230 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1044 | 0.230 |
Why?
| | Glutamine | 3 | 2019 | 91 | 0.230 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 26 | 0.220 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 40 | 0.220 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 156 | 0.220 |
Why?
| | Succinates | 1 | 2023 | 18 | 0.220 |
Why?
| | Obesity | 5 | 2021 | 2523 | 0.220 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 63 | 0.220 |
Why?
| | Lactates | 1 | 2023 | 83 | 0.220 |
Why?
| | Furin | 1 | 2022 | 13 | 0.220 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 27 | 0.210 |
Why?
| | Liver | 3 | 2019 | 1693 | 0.210 |
Why?
| | Equidae | 1 | 2022 | 4 | 0.210 |
Why?
| | src-Family Kinases | 1 | 2023 | 88 | 0.210 |
Why?
| | Bicycling | 1 | 2023 | 75 | 0.210 |
Why?
| | Glucose | 3 | 2017 | 904 | 0.210 |
Why?
| | Histiocytosis | 1 | 2022 | 8 | 0.210 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 175 | 0.200 |
Why?
| | Sulfonamides | 3 | 2020 | 447 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 109 | 0.200 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 5 | 0.200 |
Why?
| | Mice, Knockout | 4 | 2023 | 2609 | 0.200 |
Why?
| | Protein Domains | 1 | 2022 | 209 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 83 | 0.200 |
Why?
| | Cholesterol | 2 | 2022 | 368 | 0.190 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 215 | 0.190 |
Why?
| | Sphingolipids | 2 | 2021 | 59 | 0.190 |
Why?
| | Resistance Training | 1 | 2023 | 124 | 0.190 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.190 |
Why?
| | Ranitidine | 1 | 2021 | 13 | 0.190 |
Why?
| | Cannabidiol | 1 | 2022 | 59 | 0.190 |
Why?
| | Erythrocyte Count | 1 | 2021 | 19 | 0.190 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 177 | 0.190 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 228 | 0.190 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 54 | 0.190 |
Why?
| | Auditory Pathways | 1 | 2021 | 54 | 0.190 |
Why?
| | Virulence Factors | 1 | 2022 | 139 | 0.190 |
Why?
| | Syndecan-1 | 1 | 2020 | 28 | 0.190 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 33 | 0.190 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 168 | 0.190 |
Why?
| | Cell Plasticity | 1 | 2021 | 24 | 0.190 |
Why?
| | Machine Learning | 2 | 2021 | 322 | 0.180 |
Why?
| | Macrophages | 4 | 2022 | 1284 | 0.180 |
Why?
| | Benzothiazoles | 2 | 2017 | 33 | 0.180 |
Why?
| | Cannabinoids | 1 | 2022 | 116 | 0.180 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 93 | 0.180 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 81 | 0.180 |
Why?
| | Stromal Cells | 1 | 2020 | 97 | 0.180 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 78 | 0.180 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 84 | 0.180 |
Why?
| | Osmotic Pressure | 1 | 2020 | 28 | 0.180 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 83 | 0.180 |
Why?
| | Macrophage Activation | 1 | 2021 | 165 | 0.180 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 347 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 262 | 0.170 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 20 | 0.170 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.170 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
| | Shock | 1 | 2020 | 76 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 192 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 174 | 0.170 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.170 |
Why?
| | Hibernation | 2 | 2019 | 72 | 0.170 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 22 | 0.170 |
Why?
| | Parabiosis | 1 | 2019 | 12 | 0.170 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 287 | 0.170 |
Why?
| | Circadian Clocks | 1 | 2019 | 44 | 0.160 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.160 |
Why?
| | Homeostasis | 2 | 2022 | 577 | 0.160 |
Why?
| | Mitochondria | 3 | 2019 | 751 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 401 | 0.160 |
Why?
| | Transcriptome | 2 | 2021 | 742 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2020 | 80 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1753 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 431 | 0.160 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 185 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2020 | 137 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 79 | 0.160 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 32 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2018 | 43 | 0.160 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 172 | 0.160 |
Why?
| | Adenosine | 2 | 2017 | 204 | 0.160 |
Why?
| | Arousal | 1 | 2019 | 153 | 0.160 |
Why?
| | Young Adult | 8 | 2021 | 10514 | 0.150 |
Why?
| | Proteostasis | 1 | 2018 | 20 | 0.150 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.150 |
Why?
| | Signal Transduction | 7 | 2022 | 4546 | 0.150 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 14 | 0.150 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 13 | 0.150 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
| | Cryopreservation | 1 | 2018 | 93 | 0.150 |
Why?
| | Time Factors | 9 | 2018 | 6182 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 230 | 0.150 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 357 | 0.150 |
Why?
| | Neoplasms | 2 | 2022 | 2121 | 0.150 |
Why?
| | Diglycerides | 1 | 2018 | 55 | 0.150 |
Why?
| | Calcium | 2 | 2022 | 1103 | 0.150 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
| | Glutaminase | 1 | 2017 | 10 | 0.150 |
Why?
| | Nicotine | 1 | 2020 | 267 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
| | Resuscitation | 2 | 2018 | 248 | 0.150 |
Why?
| | Breast Neoplasms | 2 | 2020 | 1872 | 0.150 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
| | Nitriles | 1 | 2018 | 152 | 0.140 |
Why?
| | Limit of Detection | 1 | 2017 | 55 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 173 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 12 | 0.140 |
Why?
| | Body Fluids | 1 | 2017 | 58 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 280 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 145 | 0.140 |
Why?
| | Citric Acid | 1 | 2016 | 30 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.140 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 63 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 116 | 0.140 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2016 | 37 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2020 | 678 | 0.140 |
Why?
| | Folic Acid | 1 | 2017 | 159 | 0.140 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 53 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2018 | 257 | 0.140 |
Why?
| | Lactic Acid | 4 | 2021 | 276 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 488 | 0.130 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 302 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 314 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 414 | 0.130 |
Why?
| | Brain Death | 1 | 2016 | 32 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | Models, Biological | 2 | 2021 | 1648 | 0.130 |
Why?
| | Bacteria | 1 | 2022 | 730 | 0.130 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 550 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 73 | 0.130 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 66 | 0.130 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 9 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 137 | 0.130 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 534 | 0.130 |
Why?
| | Middle Aged | 9 | 2021 | 27092 | 0.130 |
Why?
| | Vasodilation | 1 | 2018 | 413 | 0.130 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.130 |
Why?
| | Pandemics | 2 | 2020 | 1339 | 0.130 |
Why?
| | Biochemistry | 1 | 2015 | 40 | 0.130 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.130 |
Why?
| | Fluid Therapy | 1 | 2016 | 122 | 0.130 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 39 | 0.130 |
Why?
| | Acidosis | 1 | 2016 | 87 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2021 | 735 | 0.130 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 134 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 246 | 0.130 |
Why?
| | Platelet Transfusion | 1 | 2015 | 63 | 0.130 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.130 |
Why?
| | Adipose Tissue | 2 | 2017 | 553 | 0.120 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 191 | 0.120 |
Why?
| | Blood Volume | 1 | 2015 | 56 | 0.120 |
Why?
| | Extinction, Biological | 1 | 2015 | 29 | 0.120 |
Why?
| | Sulfur | 3 | 2022 | 45 | 0.120 |
Why?
| | Citrates | 1 | 2014 | 44 | 0.120 |
Why?
| | Cells, Cultured | 5 | 2021 | 3922 | 0.120 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 42 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 145 | 0.120 |
Why?
| | Linear Models | 1 | 2017 | 778 | 0.120 |
Why?
| | Health Status | 1 | 2019 | 728 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 610 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 221 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 845 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1138 | 0.120 |
Why?
| | Sodium Chloride | 1 | 2014 | 136 | 0.120 |
Why?
| | Methionine | 3 | 2020 | 145 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 160 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2091 | 0.110 |
Why?
| | Fetal Development | 1 | 2016 | 248 | 0.110 |
Why?
| | Proteolysis | 3 | 2020 | 145 | 0.110 |
Why?
| | Dietary Supplements | 1 | 2017 | 460 | 0.110 |
Why?
| | Prognosis | 1 | 2021 | 3346 | 0.110 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 1893 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 713 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 388 | 0.110 |
Why?
| | Peptide Fragments | 1 | 2017 | 675 | 0.110 |
Why?
| | Blood Transfusion | 3 | 2022 | 277 | 0.110 |
Why?
| | Adenine | 1 | 2014 | 221 | 0.110 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 344 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 617 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 450 | 0.110 |
Why?
| | Diet | 1 | 2020 | 1074 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2017 | 595 | 0.110 |
Why?
| | Aged | 5 | 2023 | 19302 | 0.110 |
Why?
| | Larva | 3 | 2020 | 193 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 449 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2016 | 521 | 0.110 |
Why?
| | Muscles | 2 | 2023 | 328 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 610 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3588 | 0.100 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 538 | 0.100 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 704 | 0.090 |
Why?
| | Microbiota | 1 | 2018 | 652 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 790 | 0.090 |
Why?
| | Insulin | 2 | 2021 | 2084 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 961 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 563 | 0.090 |
Why?
| | Cell Proliferation | 4 | 2019 | 2198 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 722 | 0.090 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 42 | 0.090 |
Why?
| | Cell Line | 3 | 2022 | 2658 | 0.090 |
Why?
| | Phenotype | 4 | 2020 | 2863 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2810 | 0.090 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 6 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 935 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 181 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1973 | 0.080 |
Why?
| | Phosphorylation | 3 | 2018 | 1572 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1361 | 0.080 |
Why?
| | Brain | 2 | 2021 | 2372 | 0.080 |
Why?
| | Diet, High-Fat | 2 | 2019 | 225 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 149 | 0.080 |
Why?
| | Macaca | 2 | 2018 | 51 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 643 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1147 | 0.070 |
Why?
| | Neurons | 1 | 2015 | 1298 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 194 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 533 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 793 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 54 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 33 | 0.070 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 349 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2378 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2018 | 433 | 0.070 |
Why?
| | Mice, Nude | 2 | 2018 | 639 | 0.070 |
Why?
| | Isotonic Solutions | 2 | 2016 | 38 | 0.070 |
Why?
| | Swine | 2 | 2018 | 705 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 17942 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1056 | 0.060 |
Why?
| | Arginine | 2 | 2016 | 242 | 0.060 |
Why?
| | Blood Glucose | 3 | 2020 | 1827 | 0.060 |
Why?
| | Cold Temperature | 2 | 2016 | 128 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1024 | 0.060 |
Why?
| | Glutathione | 2 | 2016 | 303 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 695 | 0.060 |
Why?
| | RNA Interference | 2 | 2017 | 438 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 4 | 0.060 |
Why?
| | Prospective Studies | 3 | 2021 | 6280 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 832 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 545 | 0.060 |
Why?
| | Mutation | 3 | 2022 | 3376 | 0.060 |
Why?
| | Respiratory Therapy | 1 | 2023 | 20 | 0.060 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 37 | 0.060 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.060 |
Why?
| | Dasatinib | 1 | 2023 | 46 | 0.050 |
Why?
| | Heme | 1 | 2023 | 56 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 97 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 126 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 50 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 67 | 0.050 |
Why?
| | Horses | 1 | 2022 | 97 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 188 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 867 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 141 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2581 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 1862 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2023 | 515 | 0.050 |
Why?
| | Quality of Life | 2 | 2023 | 2390 | 0.050 |
Why?
| | Dogs | 1 | 2022 | 344 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 796 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 4960 | 0.050 |
Why?
| | Oncogenes | 1 | 2021 | 104 | 0.050 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 6 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2021 | 78 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 41 | 0.050 |
Why?
| | Candidiasis | 1 | 2021 | 58 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2022 | 221 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 105 | 0.050 |
Why?
| | Immunity | 1 | 2021 | 126 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2023 | 305 | 0.050 |
Why?
| | Point Mutation | 1 | 2021 | 218 | 0.050 |
Why?
| | Muscle Strength | 1 | 2023 | 278 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 86 | 0.050 |
Why?
| | Cystine | 1 | 2020 | 14 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2021 | 204 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 633 | 0.050 |
Why?
| | Genome | 1 | 2022 | 274 | 0.050 |
Why?
| | Longevity | 1 | 2021 | 136 | 0.050 |
Why?
| | Cochlea | 1 | 2021 | 89 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 4 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 52 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 65 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 806 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 356 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 200 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 30 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 205 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 175 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 132 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1664 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 136 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 6 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 68 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 180 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 27 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 156 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 43 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 431 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 917 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4447 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 86 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 511 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 60 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 188 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 574 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 11 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 296 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 480 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 206 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2366 | 0.040 |
Why?
| | Formic Acid Esters | 1 | 2017 | 4 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 10 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 15 | 0.040 |
Why?
| | Biological Transport | 1 | 2018 | 375 | 0.040 |
Why?
| | Metabolism | 1 | 2017 | 36 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2017 | 71 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 214 | 0.040 |
Why?
| | Azacitidine | 1 | 2018 | 130 | 0.040 |
Why?
| | Pyrroles | 1 | 2018 | 185 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 431 | 0.040 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 34 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 209 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 141 | 0.040 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| | Fluorenes | 1 | 2017 | 38 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1277 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 337 | 0.040 |
Why?
| | Blood Proteins | 1 | 2019 | 238 | 0.040 |
Why?
| | Anaerobiosis | 1 | 2017 | 49 | 0.040 |
Why?
| | Femoral Fractures | 1 | 2017 | 67 | 0.040 |
Why?
| | Cystathionine | 1 | 2016 | 25 | 0.040 |
Why?
| | Cell Respiration | 1 | 2017 | 74 | 0.040 |
Why?
| | Periodicity | 1 | 2016 | 56 | 0.040 |
Why?
| | Weaning | 1 | 2016 | 48 | 0.040 |
Why?
| | Nucleotides | 1 | 2017 | 113 | 0.040 |
Why?
| | Gene Expression | 1 | 2022 | 1443 | 0.040 |
Why?
| | Erythrocyte Aging | 1 | 2016 | 6 | 0.040 |
Why?
| | Ubiquitination | 1 | 2017 | 86 | 0.040 |
Why?
| | Proteins | 1 | 2022 | 922 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 150 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2022 | 740 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 5 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 28 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | NADP | 1 | 2016 | 42 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 969 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 243 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 40 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 43 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 93 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 222 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 136 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 471 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 839 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 77 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 39 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 51 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 59 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 214 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 309 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 73 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 577 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 132 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 211 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 547 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 261 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 271 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 227 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 213 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 235 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5555 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 173 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1391 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1227 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 370 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 275 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1172 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 141 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 192 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 174 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 125 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1535 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 211 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 133 | 0.030 |
Why?
| | Europe | 1 | 2015 | 343 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 191 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 92 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 246 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1084 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1443 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 590 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 399 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 322 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 295 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 868 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 468 | 0.030 |
Why?
| | Running | 1 | 2017 | 209 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1034 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 450 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 325 | 0.030 |
Why?
| | Skull | 1 | 2015 | 118 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 541 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 281 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 445 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 1974 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 960 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2591 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1317 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 962 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1244 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 526 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 824 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1219 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3056 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 390 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 504 | 0.030 |
Why?
| | Athletes | 1 | 2016 | 323 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 302 | 0.030 |
Why?
| | Fetus | 1 | 2016 | 703 | 0.030 |
Why?
| | NF-kappa B | 1 | 2015 | 640 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 1918 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2003 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2796 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6435 | 0.020 |
Why?
| | United States | 1 | 2015 | 12323 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|